Nia Impact Advisors, LLC Organon & Co. Transaction History

Nia Impact Advisors, LLC

$246 Million
Q1 2025

A detailed history of Nia Impact Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Nia Impact Advisors, LLC holds 224,475 shares of OGN stock, worth $2.03 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares

224,475

Previous 223,157 0.59%

Holding current value

$2.03 Million

Previous $3.33 Million 0.39%

% of portfolio

1.36%

Previous 1.16%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$14.29 - $16.41 $18,834 - $21,628	1,318 Added 0.59%	224,475 $3.34 Million
Q4 2024 Feb 14, 2025	BUY	$14.44 - $18.83 $558,163 - $727,854	38,654 Added 20.95%	223,157 $3.33 Million
Q3 2024 Nov 14, 2024	BUY	$18.65 - $23.03 $457,353 - $564,764	24,523 Added 15.33%	184,503 $3.53 Million
Q2 2024 Aug 08, 2024	SELL	$17.45 - $21.96 $117,002 - $147,241	-6,705 Reduced 4.02%	159,980 $3.31 Million
Q1 2024 May 15, 2024	BUY	$13.78 - $18.8 $811,297 - $1.11 Million	58,875 Added 54.61%	166,685 $3.13 Million
Q2 2023 Aug 11, 2023	SELL	$19.27 - $24.63 $34,801 - $44,481	-1,806 Reduced 1.65%	107,810 $2.24 Million
Q1 2023 May 03, 2023	SELL	$21.42 - $32.08 $127,277 - $190,619	-5,942 Reduced 5.14%	109,616 $2.58 Million
Q4 2022 Feb 09, 2023	BUY	$23.31 - $28.61 $188,857 - $231,798	8,102 Added 7.54%	115,558 $3.23 Million
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $31,589 - $46,237	-1,350 Reduced 1.24%	107,456 $2.51 Million
Q2 2022 Aug 05, 2022	BUY	$31.66 - $38.9 $833,101 - $1.02 Million	26,314 Added 31.9%	108,806 $3.67 Million
Q1 2022 May 11, 2022	BUY	$30.45 - $39.36 $2.51 Million - $3.25 Million	82,492 New	82,492 $2.88 Million

Others Institutions Holding OGN

# of Institutions

805

Shares Held

198M

Call Options Held

1.84M

Put Options Held

1.41M

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $2.3B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nia Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nia Impact Advisors, LLC with notifications on news.

Account

Nia Impact Advisors, LLC Organon & Co. Transaction History